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The incidence of surgical site infections (SSIs) was 24% in a district 
hospital in Tanzania. Wound classification was not an independent 
risk factor for SSI, indicating that risk scores developed in indus-
trialized countries may require adjustments for nonindustrialized 
countries. The National Nosocomial Infections Surveillance system 
score required adjustments to reliably predict SSI, probably to ac-
count for improper hygiene and the lack of adjustment for the 
duration of surgery (defined as the 75th percentile of the duration 
for each type of operative procedure) to reflect local circumstances. 
Multidrug-resistant pathogens, such as methicillin-resistant Staph-
ylococcus aureus and gram-negative pathogens expressing broad-
spectrum /3-lactamases, have already emerged. 
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All over the world, surgical site infections (SSIs) are a po-
tential severe danger to surgical patients.13 Nonindustrialized 
countries face this problem on a larger scale because of the 
infrastructural and economic limitations of many hospi-
tals,4'5,6,7 Prospective studies on the incidence of, the risk fac-
tors for, and consequences of SSIs in sub-Saharan Africa are 
available for tertiary care and teaching hospitals but not for 
primary and secondary care institutions.8,9 Therefore, we as-
sessed the incidence, risk factors, causative pathogens, and 
susceptibility patterns associated with SSI in a secondary care 
hospital in rural Tanzania. 
M E T H O D S 
This study was performed in the 82-bed department of gen-
eral surgery that included gynecology and obstetrics at St. 
Francis Designated District Hospital, a 371-bed hospital in 
Ifakara (southern Tanzania) that is the only health facility 
with a surgical department in a region with more than 550,000 
people. A mean of 155 surgical interventions are performed 
per month in the 2 main operating rooms. Surgical instru-
ments are reprocessed by dry heat at 150°C for 60 minutes, 
without monitoring. Worn out and heavily used muslins with 
tiny holes were used as drapes and gowns. Between November 
2003 and March 2004, all consecutive adult patients admitted 
for surgery were enrolled. The study was approved by the 
ethics committees of the participating insitutions in Tanzania 
and Switzerland. Written informed consent was obtained for 
every patient participating in our study. 
Data were collected by 3 study nurses 24 hours per day 
and 7 days per week. They recorded patients' characteris-
tics (Table 1), National Nosocomial Infections Surveillance 
system (NNIS) index variables, and laboratory results.2 All 
infections were identified and documented by one of the 
investigators (J.F.). Patients were assessed daily during hos-
pitalization and for the last time 30 days after surgery. They 
received a free diagnostic workup and were reimbursed for 
travel expenses associated with the follow-up visit. In case of 
a suspected SSI, a digital picture of the infection site was 
taken, and swab specimens from the wound were incubated 
overnight. All swab specimens were analyzed by Gram stain-
ing and culture on agar (ChroMagar Orientation and Chro-
Magar S. aureus media) in the local laboratory. Colonies from 
cultures were transferred in transport medium and analyzed 
monthly at the Microbiology Laboratory, University Hospital 
Basel (Basel, Switzerland) according to standard methods. All 
pathogens were stored at — 70°C, in accordance with CLSI 
recommendations.10 
The risk of SSI in relation to patient characteristics was 
assessed using univariate and multivariate statistical analyses. 
RESULTS 
Six hundred thirteen (99.2%) of 618 eligible patients were 
included in the study. Five patients were not enrolled either 
because they refused to participate or because no major pro-
cedure was done (ie, the patient left the clinic the same day 
the intervention was done). One hundred forty-four (23.5%) 
of the 613 patients developed an SSI. According to the Centers 
for Disease Control and Prevention definitions, 55 (38.2%) 
of the patients had a superficial SSI, 67 (46.5%) had a deep 
SSI, and 22 (15.3%) had an organ/space SSI. Thirteen patients 
(2.1%) died, and 2 of these deaths were directly attributable 
to SSI. For 30 patients (21%), the SSI was identified after 
discharge from the hospital; 9 of these 30 were readmitted 
because of SSIs. 
The median duration of hospital stay was 5 days (range, 
1-70 days), and the median duration of follow-up was 28 
days. Two hundred eighty-two (46%) of the 613 patients 
failed to return for the follow-up visit, mainly because they 
had to travel for up to 1 day to return to the hospital. The 
median time for SSI detection was 6 days after surgery. Most 
patients were young (mean age [ ± S D ] , 32 ± 16 years), fe-
male (83%), and hospitalized for obstetrical or gynecological 
problems (eg, emergency cesarean section) (Table 1). 
In the univariate analysis, risk factors for SSI were an Amer-
ican Society of Anesthesiologists (ASA) physical status clas-
https:/www.cambridge.org/core/terms. https://doi.org/10.1086/509855
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 20:26:33, subject to the Cambridge Core terms of use, available at
1 4 0 2 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY DECEMBER 2 0 0 6 , VOL. 2 7 , NO. 12 
Demographic and Clinical Characteristics of Patients in the Study 
Variable 
Female sex 
Age, mean y ± SD 
Type of diagnosis at admission 
Obstetric or gynecological 
Visceral (including hernia) 
Orthopedic 
Urological 
Dermatological or angiological 
Ear, nose, or throat 
Preoperative clinical characteristics 
Body temperature >37.5°C 
Tachycardia 
Hypertension 
Underweight (BMI <18) 
Obesity (BMI >25) 
Anemiab 
Hyperglycemia (glucose level >6.4 mmol/L) 
Presence of Plasmodium species 
ASA physical status classification 
1 
2 
3 
4 
5 
Type of surgical intervention 
Emergency surgery 
Cesarean section 
Hysterectomy 
Laparotomy 
Hernia repair 
Hydrocele repair 
Orthopedic 
Other 
Wound classification 
Clean 
Clean-contaminated 
Dirty 
Dirty-infected 
Perioperative management 
General anesthesia 
Intensive care unit 
Blood transfusion 
Urinary catheter 
All patients 
(n = 613) 
509 (83) 
32.0 ± 13.6 
462 (75) 
91 (15) 
28 (5 ) 
18(3) 
6 ( 1 ) 
8 ( 1 ) 
75 (13) 
24(4) 
159 (26) 
61 (11) 
101 (18) 
176 (77) 
72 (15) 
40 (9) 
463 (76) 
80 (13) 
45(7) 
22(4) 
0 ( 0 ) 
354 (61) 
362 (59) 
28 (4 ) 
46 (8) 
43 (7) 
24 (4 ) 
20 (3) 
90 (15) 
123 (20) 
404 (66) 
69 (11) 
17(3) 
208 (34) 
94 (15) 
42 (7 ) 
475 (79) 
Patients 
with SSI 
(n = 144) 
113 (22) 
32.6 ± 13.8 
106 (23) 
22 (24) 
10 (36) 
5 (28) 
1 (17) 
0 (0) 
13 (17) 
9 (38) 
39 (25) 
11 (18) 
29 (29) 
44 (25) 
21 (29) 
13 (33) 
94 (20) 
25 (32) 
16 (36) 
9 (41) 
0 (0) 
86 (24) 
87 (24) 
10 (36) 
10 (22) 
4 (9) 
11 (46) 
6 (30) 
16 (18) 
21 (17) 
93 (23) 
22 (32) 
8 (47) 
58 (28) 
29 (31) 
15 (36) 
118 (25) 
Risk ratio 
(95% CI) 
0.7 (0.5-1.0) 
Reference 
1.1 (0.7-1.6) 
1.6 (0.9-2.7) 
1.2 (0.6-2.6) 
0.7 (0.1-4.4) 
0 
0.7 (0.4-1.3) 
1.7 (1.0-2.9) 
1.1 (0.8-1.4) 
0.7 (0.4-1.4) 
1.3 (0.9-1.9) 
0.9 (0.6-1.5) 
1.3 (0.9-2.0) 
1.4 (0.9, 2.2) 
Reference 
1.5 (1.1-2.2) 
1.8 (1.1-2.7) 
2.0 (1.2-3.4) 
1.1 (0.7-1.3) 
Reference 
1.5 (0.9-2.5) 
0.9 (0.5-1.6) 
0.4 (0.2-1.0) 
1.9 (1.2-3.1) 
1.3 (0.6-2.5) 
0.7 (0.5-1.2) 
Reference 
1.4 (0.9, 2.1) 
1.9 (1.1-3.1) 
2.8 (1.5-5.2) 
1.3 (1.0-1.8) 
1.4 (1.0-2.0) 
1.5 (1.0-2.3) 
1.3 (0.9-2.0) 
p . 
.1 
0.4 
.3 
.1 
.6 
.9 
.1 
.7 
.2 
.2 
0.006 
.7 
<.01 
.01 
.06 
.06 
.08 
.14 
N O T E . Data are no. (%) of assessed patients, unless otherwise specified. ASA, American Society of Anesthesiologists; 
BMI, body mass index; CI, confidence interval; SSI, surgical site infection. 
" P values from the contingency-table x2 (single variable) analyses. 
b
 Hemoglobin <120 g/L (females) or <140 g/L (males). 
sification of 2 or higher, duration of surgery greater than the 
75th percentile of the duration for the relevant type of op-
erative procedure, type of intervention, and wound classi-
fication of dirty or dirty-infected (Table 1). There was no 
significant effect found for any patient-related risk factors 
tested (eg, clinical data, such as body mass index, or labo-
ratory findings, such as anemia or hyperglycemia) (Table 1). 
Only 2 of these risk factors remained significantly associated 
with SSI in the multivariate analysis. First, patients with an 
ASA classification of 2-4 (no score of 5 was ever reported) 
had a significantly higher risk of SSI (P< .05; Table 1). Sec-
ond, patients with relatively long durations of operation, de-
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fined as a duration longer than the 75th percentile of the 
local value for duration of surgery, had an increased risk of 
SSI (relative risk, 1.9 [95% confidence interval, 1.4-2.6]; x2, 
16.2; P<.01) (Table 2). However, only 10 operations had 
durations longer than the 75th percentile of the international 
value for duration of surgery.2 Therefore, a meaningful com-
parison between durations relative to the local 75th percentile 
and durations relative to the international 75th percentile was 
not feasible. Adjustment for these 2 variables allowed us to 
account for the effects of the other risk factors, in particular 
for the effect of the wound classification score and the type 
of surgical intervention. 
Staphylococcus aureus was isolated from 48 (37%) of the 
144 patients with SSI, Escherichia coli from 15 (11%), and 
Enterococcus species from 7 (5%). Other clinically relevant 
bacteria, such as Klebsiella species, Proteus species, Entero-
bacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spe-
cies were found in 17 patients (12%). Instances in which 
coagulase-negative staphylococci, Corynebacterium species, or 
Bacillus species were detected or in which culture yielded no 
growth (noted for 14 patients) were grouped together under 
the category "no clinically significant organism detected"; this 
category was noted for 47 patients (35%). Surprisingly, we 
identified 1 strain of methicillin-resistant S. aureus in this 
remote hospital. In addition, 18% of all gram-negative path-
ogens produced extended-spectrum (3-lactamase (ESBL). Three 
Enterococcus isolates were resistant to vancomycin. 
D I S C U S S I O N 
The incidence of SSI in our hospital in Tanzania was high, 
compared with the incidence in industrialized countries.1,2 
However, hospitals in nonindustrialized countries indicate 
similar rates.11'12 Eriksen et al.8 reported an SSI rate of 19% 
at the Kilimanjaro Christian Medical Center, Tanzania, and 
Kotisso et al.9 reported an overall rate of 21% in Ethiopia. 
However, these studies were performed in tertiary care and 
teaching hospitals. For small hospitals, such data are not avail-
able. The proportion of SSIs that were deep or organ/space 
infections was 62% in our study, which is higher than pro-
portions reported in the literature.13 In a study from Bolivia 
by Soleto et al.,14 it was found that 93% of SSIs were super-
ficial, 4% were deep, and 2% were organ/space infections. 
Eriksen et al.8 reported that in their facility in Tanzania, 69% 
were deep SSIs, 21% were superficial SSIs, and 10% were 
organ/space SSIs. 
Only an ASA classification greater than 1 and duration of 
the operation longer than the local 75th percentile for du-
ration of surgery turned out to be significant risk factors for 
SSI. Interestingly, wound classification was not an indepen-
dent predictor of SSI in the multivariate logistic regression 
analysis. Values for the duration of surgery were very short, 
compared with durations in industrialized countries; only 10 
operations had a duration longer than the 75th percentile of 
the duration of surgery used in the NNIS index. A duration 
of surgery longer than the local 75th percentile value was a 
strong risk factor for SSI. Campos et al.15 also recommended 
that this parameter be adjusted on the basis of data from the 
local hospital before it is used to predict SSIs. We assume 
that the short operation time is a factor associated with pro-
tection against SSIs. 
Several reasons may explain the high SSI rate and the fact 
that wound classification was not an independent predictor 
for SSI. First, surgical instruments were supposed to be pro-
cessed by dry heat at 150°C for 60 minutes, as there was no 
TABLE 2. Association Between Duration of Surgery and Risk of Surgical Site Infection 
(SSI), According to Operative Procedure 
Procedure 
Cesarean section 
Hysterectomy 
Laparotomy 
Hernia repair" 
Hydrocele repair* 
Orthopedic intervention 
All 
Duration of 
surgery, min 
Median 
30 
32 
30 
19 
19 
30 
28 
75th 
percentile 
35 
42 
40 
29 
30 
40 
35 
by 
No. (%) of patients, 
relative duration of surgery 
<75th 
percentile 
All 
266 
22 
36 
28 
14 
16 
459 
With SSI 
56 (21) 
7(32) 
5(14) 
3(11) 
8 (57) 
4(25) 
95 (21) 
P 
All 
88 
7 
9 
9 
4 
3 
137 
>75th 
srcentile 
With SSI 
29 (33) 
3 (43) 
4 (44) 
0 
2(50) 
2(67) 
44 (32) 
NOTE. All values for the 75th percentile of the distribution of times for the intervention are 
for the local area of the study. For patients with a duration of surgery greater than the 75th 
percentile value, the relative risk of SSI was 1.6 (95% confidence interval, 1.2-2.0; x2> 9.7; P = 
.002). 
" Excluding 6 patients who underwent both hernia and hydrocele operations, of whom only 1 
had an SSI. 
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working autoclave at the time of our investigation. However, 
the thermometer and timer were broken. Hence, there were 
no sterile instruments, by the standards of industrialized 
countries, and, consequently, theoretically none of the wounds 
could have been classified as clean. Pathogens may have been 
introduced by contaminated instruments into deeper layers 
during surgical intervention. This may explain the shift from 
superficial to deep and organ/space SSIs. Holes in overused 
and improperly reprocessed surgical drapes may also have 
increased the risk of intraoperative contamination. Second, 
a high number of surgical interventions (up to 30) were con-
ducted each day, but only 7 instrument sets were available. 
Appropriate reprocessing was jeopardized because there was 
not enough time for each cleaning step. Third, a high rate 
of patient turnover interferes with appropriate assessment and 
preparation of patients. Up to 25 operations (minor inter-
ventions included) were performed by a single surgeon each 
day of duty. 
S. aureus was the most frequently isolated pathogen, as has 
been reported in other studies from Tanzania.91617 Impor-
tantly, we found multidrug resistance among gram-negative 
pathogens that produced ESBL, and we found enterococci 
that were resistant to vancomycin. Enterobacteriaceae that 
produce ESBL are reported with varying prevalence from all 
over the world.'* The genetic diversity and complexity of 
Klebsiella pneumoniae strains have been described in South 
Africa and Kenya.19,20 To the best of our knowledge, this is 
the first report from rural Tanzania of an incidence as high 
as 18% for ESBL-producing pathogens involved in SSI. 
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